bluebird bio Inc BLUE:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 1:49 PM EDT
5.96quote price arrow up+0.16 (+2.67%)
Volume
6,332,499
52 week range
2.87 - 17.85
Loading...
  • Open5.47
  • Day High6.02
  • Day Low5.44
  • Prev Close5.81
  • 52 Week High17.85
  • 52 Week High Date11/05/21
  • 52 Week Low2.87
  • 52 Week Low Date06/02/22

Key Stats

  • Market Cap460.02M
  • Shares Out77.12M
  • 10 Day Average Volume13.36M
  • Dividend-
  • Dividend Yield-
  • Beta1.40
  • YTD % Change-40.39

KEY STATS

  • Open5.47
  • Day High6.02
  • Day Low5.44
  • Prev Close5.81
  • 52 Week High17.85
  • 52 Week High Date11/05/21
  • 52 Week Low2.87
  • 52 Week Low Date06/02/22
  • Market Cap460.02M
  • Shares Out77.12M
  • 10 Day Average Volume13.36M
  • Dividend-
  • Dividend Yield-
  • Beta1.40
  • YTD % Change-40.39

RATIOS/PROFITABILITY

  • EPS (TTM)-7.05
  • P/E (TTM)-0.85
  • Fwd P/E (NTM)-1.78
  • EBITDA (TTM)-474.768M
  • ROE (TTM)-87.14%
  • Revenue (TTM)6.09M
  • Gross Margin (TTM)-443.95%
  • Net Margin (TTM)-8,333.90%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date11/03/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On bluebird bio Inc

There is no recent news for this security.

Profile

MORE
bluebird bio, Inc. is a biotechnology company. The Company is principally focused on researching, developing and commercializing gene therapies for genetic diseases. The Company’s gene therapy programs in genetic diseases include programs for B-thalassemia; LentiGlobin product candidate as a treatment for sickle cell disease (SCD), and elivaldogene autotemcel (eli-cel) as a treatment for cerebral adrenoleukodystrophy (CALD). It is using a lentiviral vector (LVV) platform, it...
Andrew Obenshain
President, Chief Executive Officer, Director
Thomas Klima
Chief Commercial and Operating Officer
Jason Cole Esq.
Chief Business Officer, Chief Strategy and Financial Officer
Address
455 Grand Union Boulevard
Somerville, MA
02145
United States

Top Peers

SYMBOLLASTCHG%CHG
TNGX
Tango Therapeutics Inc
4.95-0.05-1.00%
GTHX
G1 Therapeutics Inc
12.58-0.23-1.80%
MGTX
MeiraGTx Holdings PLC
9.77-0.13-1.31%
CELU
Celularity Inc
2.83-0.07-2.59%
RPTX
Repare Therapeutics Inc
12.20-0.07-0.57%